|
|
GlaxoSmithKline (GSK)’s vision is to help Australians do more, feel better and live longer.
Our two operating groups – GSK Pharmaceuticals and GSK Consumer Healthcare – strive each day to achieve this vision through our medicines and vaccines, significant exports, research and development, and community activities.
We invest more than $35 million a year in Australian R&D, and contribute to export revenue through pharmaceutical and consumer healthcare exports.
We supply more than 25 per cent of the world's medicinal opiate needs.
Our vaccines help protect Australians from illness, and literally millions of Australians use our consumer healthcare products, such as Macleans and Panadol.
Which is why we can say, with confidence and considerable pride, that we helped someone today.
 |
Economic Contributions
GSK makes a significant contribution to the Australian economy through employment, exports, manufacturing and local investment.
|
|
 |
Our History
GSK heritage companies have operated in Australia since 1886
|
|
 |
Policies and Issues
GSK works extensively with all levels of government as well as the broader Australian community to assist in building a strong local pharmaceutical industry, which delivers better health outcomes for all Australians.
|
|
 |
|
